Phytanic acid - An overlooked bioactive fatty acid in dairy fat?

Annals of the New York Academy of Sciences

Volumn 1190, Issue , 2010, Pages 42-49

  Hellgren, Lars I ^a  

^a TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

Author keywords

Peroxisome proliferator activated receptor; Phytanic acid; Phytol; Pristanic acid; Prostate cancer; Retinoid X receptor; Uncoupler protein 1

Indexed keywords

2 METHYLACYL COENZYME A RACEMASE; CELL PROTEIN; CHLOROPHYLL; FATTY ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA AGONIST; PHYTANIC ACID; RETINOID X RECEPTOR; UNCLASSIFIED DRUG; UNCOUPLER PROTEIN 1;

ADIPOCYTE; CANCER RISK; CATTLE; CELL DIFFERENTIATION; CONFERENCE PAPER; DAIRY PRODUCT; ENERGY BALANCE; FATTY ACID OXIDATION; GENE EXPRESSION; GLUCOSE METABOLISM; HUMAN; LIPID METABOLISM; LIPID STORAGE; MEAT; PROSTATE CANCER; PROTEIN EXPRESSION; SINGLE NUCLEOTIDE POLYMORPHISM;

ANIMALIA; BOS;

EID: 77950274760     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2009.05254.x     Document Type: Conference Paper

References (43)

1. Steyn, N.P. et al. 2004. Diet, nutrition and the prevention of type 2 diabetes. Public Health Nutr. 7: 147-165.
2. Biong, A.S., P. Berstad & J.I. Pedersen. 2006. Biomarkers for intake of dairy fat and dairy products. Eur. J. Lipid Sci. Tech. 108: 827-834.
3. Smedman, A.E. et al. 1999. Pentadecanoic acid in serum as a marker for intake of milk fat: relations between intake of milk fat and metabolic risk factors. Am. J. Clin. Nutr. 69: 22-29.
4. Warensjo, E. et al. 2004. Estimated intake of milk fat is negatively associated with cardiovascular risk factors and does not increase the risk of a first acute myocardial infarction. A prospective case-control study. Br. J. Nutr. 91: 635-642.
5. Hodge, A.M. et al. 2007. Plasma phospholipid and dietary fatty acids as predictors of type 2 diabetes: interpreting the role of linoleic acid. Am. J. Clin. Nutr. 86: 189-197.
6. Jensen, R.G. 2002. The composition of bovine milk lipids: January 1995 to December 2000. J. Dairy Sci. 85: 295-350.
7. LindmarkMånssona, H. 2008. Fatty acids in bovine milk fat. Food Nutr. Res. 52: DOI: 10.3402/fnr.v52i0.1821.
8. Roche, H.M. et al. 2001.Conjugated linoleic acid: a novel therapeutic nutrient? Nutr.Res. Rev. 14: 173-187.
9. Kitareewan, S. et al. 1996. Phytol metabolites are circulating dietary factors that activate the nuclear receptor RXR. Mol. Biol. Cell 7: 1153-1166.
10. Ellinghaus, P. et al. 1999. Phytanic acid activates the peroxisome proliferator-activated receptor alpha (PPARalpha) in sterol carrier protein 2-/ sterol carrier protein x-deficient mice. J. Biol. Chem. 274: 2766-2772.
11. Brown, P.J. et al. 1993. Diet and Refsums disease - the determination of phytanic acid and phytol in certain foods and the application of this knowledge to the choice of suitable convenience foods for patients with Refsums disease. J. Hum. Nutr. Diet. 6: 295-305.
12. Allen, N.E. et al. 2008. Phytanic acid: measurement of plasma concentrations by gas-liquid chromatographymass spectrometry analysis and associations with diet and other plasma fatty acids. Br. J. Nutr. 99: 653-659.
13. Patton, S. & A.A. Benson. 1966. Phytol metabolism in the bovine. Biochim. Biophys. Acta 125: 22-32.
14. Leiber, F. et al. 2005.Astudy on the causes for the elevated n-3 fatty acids in cows' milk of alpine origin. Lipids 40: 191-202.
15. Lough, A.K. 1977. Phytanic acid content of lipids of bovine tissues and milk. Lipids 12: 115-119.
16. Van Den Brink, D. & R. Wanders. 2006. Phytanic acid: production from phytol, its breakdown and role in human disease. Cell. Mol. Life Sci. 63: 1752-1765.
17. Mukherji, M. et al. 2003. The chemical biology of branched-chain lipid metabolism. Prog. Lipid Res. 42: 359-376.
18. Verhoeven, N.M.& C. Jakobs. 2001.Human metabolism of phytanic acid and pristanic acid. Prog. Lipid Res. 40: 453-466.
19. Wierzbicki, A.S. 2007. Peroxisomal disorders affecting phytanic acid--oxidation: a review. Biochem. Soc. Trans.035: 881-886.
20. Gloerich, J. et al. 2005. A phytol-enriched diet induces changes in fatty acid metabolism in mice both via PPAR{alpha}-dependent and -independent pathways. J. Lipid Res. 46: 716-726.
21. Hanhoff, T. et al. 2005. Branched-chain fatty acids as activators of peroxisome proliferator-activated receptors. Eur. J. Lipid Sci. Tech. 107: 716-729.
22. Heim, M. et al. 2002. Phytanic acid, a natural peroxisome proliferator-activated receptor (PPAR) agonist, regulates glucose metabolism in rat primary hepatocytes. FASEB J. 16: 718-720.
23. Lemotte, P.K., S. Keidel & C.M. Apfel. 1996. Phytanic acid is a retinoid X receptor ligand. Eur. J. Biochem. 236: 328-333.
24. Al-Dirbashi, O.Y. et al. 2008. Rapid UPLC-MS/MS method for routine analysis of plasma pristanic, phytanic, and very long chain fatty acid markers of peroxisomal disorders. J. Lipid Res. 49: 1855-1862.
25. Schl̈ter, A. et al. 2002. Phytanic acid, but not pristanic acid,mediates the positive effects of phytol derivatives on brown adipocyte differentiation. FEBS Lett. 517: 83-86.
26. Zomer, A.W. et al. 2000. Pristanic acid and phytanic acid: naturally occurring ligands for the nuclear receptor peroxisome proliferator-activated receptor alpha. J. Lipid Res. 41: 1801-1807.
27. Hostetler, H.A., A.B. Kier & F. Schroeder. 2006. Verylong- chain and branched-chain fatty acyl-CoAs are high affinity ligands for the peroxisome proliferator-activated receptor alpha (PPARalpha). Biochemistry 45: 7669-7681.
28. Sonoda, J., L. Pei & R.M. Evans. 2008. Nuclear receptors: decoding metabolic disease. FEBS Letters 582: 2-9.
29. Hanhoff, T. et al. 2001. Pristanic acid is activator of peroxisome proliferator activated receptor alpha. Eur. J. Lipid Sci. Tech. 103: 75-80.
30. Goto, T. et al. 2005. Phytol directly activates peroxisome proliferator-activated receptor alpha (PPAR alpha) and regulates gene expression involved in lipid metabolism in PPAR alpha-expressing HepG2 hepatocytes. Biochem. Biophys. Res. Commun. 337: 440-445.
31. Tontonoz, P. et al. 1997. Terminal differentiation of humanliposarcomacells induced by ligands for peroxisome proliferator-activated receptor-γ and the retinoid X receptor. P. Nat. Acad. Sci. USA 94: 237-241.
32. Schl̈ter,A. et al. 2002. The chlorophyll-derived metabolite phytanic acid induces white adipocyte differentiation. 26: 1277-1280.
33. Schl̈ter, A. et al. 2002. Phytanic acid, a novel activator of uncoupling protein-1 gene transcription and brown adipocyte differentiation. Biochem. J. 362: 61-69.
34. Crisan, M. et al. 2008. A reservoir of brown adipocyte progenitors in human skeletal muscle. Stem Cells 26: 2425-2433.
35. Seedorf,U. et al. 1998. Defective peroxisomal catabolism of branched fatty acyl coenzyme A in mice lacking the sterol carrier protein-2 sterol carrier protein-x gene function. Genes Dev. 12: 1189-1201.
36. Steinberg, D. 1995. Refsum's disease. In The Metabolic and Molecular Bases of Inherited Disease. C.R. Scriver,et al. Eds.: 2351-2369. McGraw Hill. New York.
37. Zandbergen, F. & J. Plutzky. 2007. PPAR-α in atherosclerosis and inflammation. Biochim. Biophys. Acta 1771: 972-982.
38. Hashimoto, T. et al. 2006. Polyunsaturated fats attenuate the dietary phytol-induced increase in hepatic fatty acid oxidation in mice. J. Nutr. 136: 882-886.
39. Lloyd, M.D. et al. 2008.α-methylacyl-CoA racemasean 'obscure' metabolic enzyme takes centre stage. FEBS J. 275: 1089-1102.
40. Xu, J. et al. 2005. Serum levels of phytanic acid are associated with prostate cancer risk. Prostate 63: 209-214.
41. Vos, S.D. et al. 1997. Effects of retinoid X receptorselective ligands on proliferation of prostate cancer cells. Prostate 32: 115-121.
42. Tang, X.-H. et al. 2007. Cell proliferation inhibition and alterations in retinol esterification induced by phytanic acid and docosahexaenoic acid. J. Lipid Res. 48: 165-176.
43. FitzGerald, L.M. et al. 2008. Sequence variants of alphamethylacyl- CoA racemase are associated with prostate cancer risk: a replication study in an ethnically homogeneous population. Prostate 68: 1373-1379.